Mandelia Ashish's Form 4/A amendment
AmendedMersana Therapeutics, Inc. (MRSN) · filed Feb 16, 2024
- Accession no.
- 0001104659-24-024929
- Filed
- Feb 16, 2024
- Rule 10b5-1 plan
- Checked
- Original filed
- Jan 17, 2024
This filing lists no transactions. It carries over 11 transactions from the original filing that it did not restate. Open-market sales total $13.6K.
This amendment restates part of 0001104659-24-004549 (filed Jan 17, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mandelia AshishCIK 0001782805 | Officer (VP, Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001104659-24-004549 (filed Jan 17, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2024 | Common Stock | MOption exerciseAcquired | +2,645 | $0.00 | $0 | 18,218 | Direct | |
| Jan 14, 2024 | Common Stock | MOption exerciseAcquired | +4,783 | $0.00 | $0 | 23,001 | Direct | |
| Jan 15, 2024 | Common Stock | MOption exerciseAcquired | +4,519 | $0.00 | $0 | 27,520 | Direct | |
| Jan 15, 2024 | Common Stock | MOption exerciseAcquired | +833 | $0.00 | $0 | 28,353 | Direct | |
| Jan 16, 2024 | Common Stock | SSaleDisposed | −5,025 | $2.71F7 | −$13,617.75 | 23,328 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2024 | Common Stock | MOption exerciseDisposed | −2,645 | $0.00 | $0 | 7,938 | Direct | |
| Jan 14, 2024 | Common Stock | MOption exerciseDisposed | −4,783 | $0.00 | $0 | 9,566 | Direct | |
| Jan 15, 2024 | Common Stock | MOption exerciseDisposed | −4,519 | $0.00 | $0 | 4,519 | Direct | |
| Jan 15, 2024 | Common Stock | MOption exerciseDisposed | −833 | $0.00 | $0 | 0 | Direct | |
| Jan 15, 2024 | Common Stock | AGrant or awardAcquired | +75,000 | $0.00 | $0 | 75,000 | Direct | |
| Jan 15, 2024 | Common Stock | AGrant or awardAcquired | +16,667 | $0.00 | $0 | 16,667 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F7
The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $2.70 to $2.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On January 17, 2024, the Reporting Person filed a Form 4 reporting the vesting of restricted stock units ("RSU"s) between January 13, 2024 and January 15, 2024 and the sale of shares of common stock on January 16, 2024 to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs (the "Original Form 4"). Due to an inadvertent arithmetic error, the number of shares beneficially owned by the Reporting Person following the receipt of the RSUs that vested on January 13, 2024 was incorrectly reported, which error also impacted the beneficial ownership figures reported following the subsequent transactions reported in the Original Form 4. This Form 4/A is being filed to correct the number of shares held by the Reporting Person as of January 16, 2024 after all transactions reported in the Original Form 4.